Glanis Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2014.
2014 New Delhi, Delhi, India Dormant Under Section 455
Last Updated:
Access Report
About Glanis Pharmaceuticals Private Limited

Glanis Pharmaceuticals Private Limited, a dormant under section 455 private limited company, was established on 13 February 2014 in New Delhi, Delhi, India. Engaging in specialty within the trading sector, it holds CIN: U51909DL2014PTC264855. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shailesh Kumar Singh (Director), Abhishek Ranjan (Director). It is based at 134/1, Taimoor Nagar, New Delhi, Delhi, 110025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2014PTC264855

  • Registration Number

    264855

  • Incorporation Date

    13 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Dormant Under Section 455

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 8 Days
Company report

Glanis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glanis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Glanis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shailesh Kumar Singh Director 13 Feb 2014 Current
Abhishek Ranjan Director 13 Feb 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glanis Pharmaceuticals.

Enhance accessibility to Glanis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Glanis Pharmaceuticals revenue growth over time
Glanis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glanis Pharmaceuticals?

Unlock access to Glanis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Glanis Pharmaceuticals?

Unlock and access historical data on people associated with Glanis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glanis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glanis Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Shailesh Kumar Singh was appointed as a Director was appointed as a Director on 13 Feb 2014 & has been associated with this company since 12 years 8 days . was completed.

  • Director Appointment

    Progress on Abhishek Ranjan was appointed as a Director was appointed as a Director on 13 Feb 2014 & has been associated with this company since 12 years 8 days . was documented.

  • Company Incorporation

    Glanis Pharmaceuticals Private Limited was registered on 13 Feb 2014 with Roc Delhi & aged 12 years 8 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glanis Pharmaceuticals Private Limited?

The CIN of Glanis Pharmaceuticals Private Limited is U51909DL2014PTC264855.

Where is Glanis Pharmaceuticals Private Limited headquartered?

Glanis Pharmaceuticals Private Limited is headquartered at 134/1, Taimoor Nagar, New Delhi, Delhi, 110025.

When was Glanis Pharmaceuticals Private Limited incorporated?

Glanis Pharmaceuticals Private Limited was incorporated on 13 February 2014.

Who are the current directors of Glanis Pharmaceuticals Private Limited?

The current directors of Glanis Pharmaceuticals Private Limited are

What is the primary industry of Glanis Pharmaceuticals Private Limited?

The primary industry of Glanis Pharmaceuticals Private Limited is Trading.

Is Glanis Pharmaceuticals Private Limited a listed company?

Glanis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Glanis Pharmaceuticals Private Limited?

The authorized capital of Glanis Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available